ストックスクリーナーアプリを入手
41.60
2.23%
-0.95
アフターアワーズ：
41.60
前日終値:
$42.55
開ける：
$41.9
24時間の取引高:
450.00K
Relative Volume:
0.89
時価総額：
$2.30B
収益：
$226.84M
当期純損益:
$3.55M
株価収益率:
594.29
EPS:
0.07
ネットキャッシュフロー:
$-12.02M
1週間 パフォーマンス:
-4.01%
1か月 パフォーマンス:
+0.74%
6か月 パフォーマンス:
-24.24%
1年 パフォーマンス:
-7.62%
1日の値動き範囲:
$41.45
$43.51
1週間の範囲:
$40.53
$43.57
52週間の値動き範囲:
$37.39
$63.00
Vericel Corp Stock (VCEL) Company Profile
VCEL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
41.60 | 2.30B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-08-09 | 開始されました | Canaccord Genuity | Buy |
| 2024-06-20 | 開始されました | TD Cowen | Buy |
| 2024-01-25 | アップグレード | Truist | Hold → Buy |
| 2023-08-08 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-11-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-11-09 | ダウングレード | Truist | Buy → Hold |
| 2022-10-14 | 再開されました | Stephens | Overweight |
| 2021-01-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 開始されました | Stephens | Overweight |
| 2020-09-17 | 開始されました | Truist | Buy |
| 2019-10-09 | 開始されました | H.C. Wainwright | Buy |
| 2019-02-28 | ダウングレード | Needham | Buy → Hold |
| 2018-08-08 | 繰り返されました | Needham | Buy |
| 2018-07-16 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | 開始されました | Leerink Partners | Outperform |
| 2018-03-06 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | 繰り返されました | Needham | Buy |
| 2018-03-05 | 繰り返されました | BTIG Research | Buy |
| 2017-06-21 | 開始されました | BTIG Research | Buy |
| 2017-03-13 | 繰り返されました | Needham | Buy |
| 2016-12-22 | 開始されました | Piper Jaffray | Overweight |
| 2016-11-09 | 繰り返されました | Needham | Buy |
| 2016-04-05 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | アップグレード | Needham | Hold → Buy |
すべてを表示
Vericel Corp (VCEL) 最新ニュース
Vericel at 2025 Truist Securities MedTech Conference: Growth Strategies Unveiled - Investing.com India
Vericel (NASDAQ:VCEL) Given “Overweight” Rating at Stephens - Defense World
Vericel (VCEL): Analyst Reiterates Overweight Rating with Stable Price Target | VCEL Stock News - GuruFocus
Handelsbanken Fonder AB Has $914,000 Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Rhumbline Advisers - Defense World
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025 - Yahoo Finance
GAMMA Investing LLC Acquires 127,028 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Analysts - Defense World
3,924 Shares in Vericel Co. (NASDAQ:VCEL) Bought by Mackenzie Financial Corp - Defense World
Canaccord Genuity reiterates Buy rating on Vericel stock with $61 target - Investing.com
Bank of America Corp DE Sells 1,579 Shares of Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel’s (VCEL) Overweight Rating Reiterated at Stephens - Defense World
What Analysts Are Saying About Vericel Stock - Benzinga
Vericel (VCEL) Maintains Overweight Rating by Stephens & Co. | V - GuruFocus
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Deutsche Bank AG - Defense World
Vericel Co. (NASDAQ:VCEL) Stock Position Cut by BNP Paribas Financial Markets - Defense World
Truist maintains Buy on Vericel shares with $52 target By Investing.com - Investing.com India
Truist maintains Buy on Vericel shares with $52 target - Investing.com
VCEL to Be Featured in Upcoming Investor Meetings | VCEL Stock N - GuruFocus
Brokerages Set Vericel Co. (NASDAQ:VCEL) Price Target at $60.86 - Defense World
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare By Investing.com - Investing.com India
Vericel at BofA Securities Conference: Growth and Innovation in Healthcare - Investing.com Australia
Transcript : Vericel Corporation Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 09 - marketscreener.com
VCEL: Upcoming Meeting and Market Insights | VCEL Stock News - GuruFocus
First Trust Advisors LP Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Sold by Tower Research Capital LLC TRC - Defense World
Vericel Corporation (NASDAQ:VCEL) Q1 2025 Earnings Call Transcript - Insider Monkey
Vericel (VCEL) Maintains Buy Rating Despite Target Price Adjustm - GuruFocus
Vericel (VCEL) Maintains Buy Rating Despite Target Price Adjustment | VCEL Stock News - GuruFocus
Vericel Corp (VCEL) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
Vericel Corp Ord earnings missed by $0.10, revenue fell short of estimates - Investing.com India
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight - GuruFocus
Earnings call transcript: Vericel Corp Q1 2025 sees revenue growth, stock steady - Investing.com India
Vericel Q1 2025 slides: record revenue offset by widening losses, raises guidance - Investing.com South Africa
Vericel Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Vericel (VCEL) Reports Slightly Lower Than Expected Q1 Revenue | VCEL Stock News - GuruFocus
Vericel's Q1 Loss Widens, Revenue Rises; 2025 Revenue Growth Outlook Reiterated - marketscreener.com
VCEL Updates Revenue and Profitability Outlook for 2023 | VCEL Stock News - GuruFocus
Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Vericel Corp SEC 10-Q Report - TradingView
Vericel Corporation (VCEL): Among Stocks with Insanely High PE Ratios Insiders Are Selling - Insider Monkey
Vericel Corp Reports Q1 2025 Earnings: EPS of -$0.23 Misses Estimates, Revenue of $52.6M Below Expectations - GuruFocus
Vericel Corporation Q1 2025 Financial Results - TradingView
Earnings Flash (VCEL) VERICEL CORPORATION Reports Q1 Revenue $52.6M, vs. FactSet Est of $53.8M - marketscreener.com
Hsbc Holdings PLC Invests $405,000 in Vericel Co. (NASDAQ:VCEL) - The AM Reporter
Earnings To Watch: Vericel Corp (VCEL) Reports Q1 2025 Result - GuruFocus
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025 - Barchart.com
Vericel’s 36% drop confirms InvestingPro’s January overvaluation warning By Investing.com - Investing.com
Vericel shareholders approve key incentive plans - Investing.com
Financial Health Report: Vericel Corp (VCEL)’s Ratios Tell a Tale - DWinneX
VCEL underperforms with a -0.26 decrease in share price - uspostnews.com
Vericel Corp (VCEL) 財務データ
収益
当期純利益
現金流量
EPS
Vericel Corp (VCEL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark | Chief Medical Officer |
Jun 02 '25 |
Sale |
40.09 |
10,000 |
400,900 |
66,237 |
0.39%
0.42%
大文字化:
|
ボリューム (24 時間):